Sharen Lee

7PUBLICATIONS
73CO-AUTHORS
Respiratory diseasesPharmaceutical delivery technologiesGenetic immunologyPredictive and prognostic markersPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 17, 2025
Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation.

Teddy Tai Loy Lee, Chengsheng Ju, Sunny Ching Long Chan

|May 22, 2025
Comparison of New-Onset Peripheral Artery Disease in Patients With Type 2 Diabetes Exposed to Sodium-Glucose Cotransporter-2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, or Glucagon-Like Peptide-1 Agonists: A Population-Based Cohort Study.

Oscar Hou-In Chou, Zhiyao Luo, Cheuk To Skylar Chung

|Nov 11, 2024
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study.

Giulio Conte, Marco Bergonti, Vincent Probst

|Oct 21, 2022
Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study.

Raymond Ngai Chiu Chan, Teddy Tai Loy Lee, Oscar Hou In Chou

|Sep 06, 2022
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes.

Jiandong Zhou, Xuejin Liu, Oscar Hou-In Chou

|Feb 08, 2022
Incident heart failure and myocardial infarction in sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitor users.

Jiandong Zhou, Sharen Lee, Keith Sai Kit Leung

Pageof 2

Frequent Collaborators

7 joint publications

Gary Tse

3 joint publications

Tong Liu

3 joint publications

Wing Tak Wong

2 joint publications

Bernard Man Yung Cheung